EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]
Siemens taps Abbott’s Pacitti for North American healthcare biz | Personnel Moves
Siemens (NYSE:SI) said it lured Abbott (NYSE:ABT) executive David Pacitti to lead its North American Healthcare business, succeeding Dr. Gregory Sorensen. Siemens Healthcare made Pacitti, whose resume includes a 14-year spell at Guidant, president of Siemens Medical Solutions USA and head of its North America regional organization effective Oct. 19. “David Pacitti’s leadership experience at Abbott […]
Conventus takes new execs from high-target rivals | Personnel Moves
Minnesota medical device maker Conventus Orthopaedics is swapping some executives, naming a new chief executive officer and new chief commercial officer in one fell swoop.
The orthopedics company appointed as its new CEO Paul Buckman, who brought with him years of medtech experience at companies including Boston Scientific and St. Jude Medical. Buckman also co-founded ev3, which Covidien acquired in 2010 for $2.6 billion. Buckman has also served on Conventus’ board of directors since 2009.
NuVasive takes a shellacking on lowered guidance | Wall Street Beat
NuVasive Inc. (NSDQ:NUVA) shares are down more than 30% today after the medical device company said yesterday that its 3rd-quarter results are likely to be substantially lower than predicted.
San Diego-based NuVasive, which makes spinal surgery implants, said 3rd-quarter sales will be about $147 million, 4.8% below the roughly $154.4 million the company expected to post.
Greatbatch proposes to mostly exit Switzerland for Indiana, Mexico | Wall Street Beat
Greatbatch (NYSE:GB) said it wants to largely shutter a pair of plants in Switzerland and relocate their operations to Ft. Wayne, Ind., and Tijuana, Mexico.
Will Advanced BioHealing pay off for Shire with a buyout deal? | Wall Street Beat
Buyout chatter pushed shares of Shire plc (FTSE:SHP) up nearly 2% in London yesterday and added 1.4% on Wall Street.
Insulet gains after paring Q4, 2011 losses | Earnings Roundup
Wall Street investors drove Insulet (NSDQ:PODD) shares up nearly 4% today ahead of the insulin management company’s 4th-quarter and full-year earnings statement.
Bedford, Mass.-based Insulet posted losses of $14.3 million, or 30 cents per share, on sales of $47.2 million for the 3 months ended Dec. 31, 2011, adding 70% to the top line and shaving 31.3 percent off of its losses, compared with the same period in 2010.
Vascular Solutions buys Escalon Medical units, ups guidance
Vascular Solutions Inc. (NSDQ:VASC) paid $5.75 million for a pair of vein-access technologies used in ultrasound procedures.
The Minneapolis-based company expects the new products to begin paying immediate dividends and upped its full-year sales guidance by $2 million.
MassDevice Network
@MassDevice
LinkedIn
YouTube